Case series data to encourage randomized trials of bladder retraining compared to antimuscarinic agents

Journal of Urology

Volumn 175, Issue 4, 2006, Pages 1411-1416

  Ghei, M ^a   Miller, R ^a   Malone Lee, J ^a  

^a WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

Muscarinic antagonists; Treatment outcome; Urinary incontinence

Indexed keywords

IMIPRAMINE; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; PLACEBO; TOLTERODINE;

ADULT; ARTICLE; BLADDER FUNCTION; BLADDER POTENTIAL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERACTIVE BLADDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URGE INCONTINENCE; URINARY FREQUENCY; URINARY URGENCY; URINE INCONTINENCE;

EID: 33644584021     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00705-6     Document Type: Article

References (16)

1. F. Haab, L. Stewart, P. Dwyer Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder Eur Urol 45 2004 420
2. C.R. Chapple, T. Rechberger, S. Al-Shukri, P. Meffan, K. Everaert, M. Huang Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder BJU Int 93 2004 303
3. N. Zinner, M. Gittelman, R. Harris, J. Susset, A. Kanellos, S. Auerbach Trospium chloride improves overactive bladder symptoms a multicenter phase III trial J Urol 171 2004 2311
4. R.A. Appell, P. Sand, R. Dmochowski, R. Anderson, N. Zinner, D. Lama Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder results of the OBJECT Study Mayo Clin Proc 76 2001 358
5. L. Cardozo, M. Lisec, R. Millard, T.O. van Vierssen, I. Kuzmin, T.E. Drogendijk Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder J Urol 172 2004 1919
6. R. Millard, J. Tuttle, K. Moore, J. Susset, B. Clarke, P. Dwyer Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity J Urol 161 1999 1551
7. K.L. Burgio, J.L. Locher, P.S. Goode, J.M. Hardin, B.J. McDowell, M. Dombrowski Behavioral vs drug treatment for urge urinary incontinence in older women a randomized controlled trial JAMA 280 1998 1995
8. P.A. Wiseman, J. Malone-Lee, G.S. Rai Terodiline with bladder retraining for treating detrusor instability in elderly people BMJ 302 1991 994
9. K. Benson, A.J. Hartz A comparison of observational studies and randomized, controlled trials N Engl J Med 342 2000 1878
10. G. Ferber Biomarkers and proof of concept Methods Find Exp Clin Pharmacol 24 suppl 2002 35
11. D.J. Farrar, J.L. Osborne The use of bromocriptine in the treatment of the unstable bladder Br J Urol 48 1976 235
12. J. Ostaszkiewicz, L. Johnston, B. Roe Habit retraining for the management of urinary incontinence in adults Cochrane Database Syst Rev 2 2004 CD002801
13. Y. Homma, J.S. Paick, J.G. Lee, K. Kawabe Japanese and Korean Tolterodine Study Group Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder a randomized, placebo-controlled trial BJU Int 92 2003 741
14. J. Concato, N. Shah, R.I. Horwitz Randomized, controlled trials, observational studies, and the hierarchy of research designs N Engl J Med 342 2000 1887
15. J. Worrall What evidence in evidence-based medicine? Philos Sci 69 2002 316
16. C. Deaney, S. Glickman, T. Gluck, J.G. Malone-Lee Intravesical atropine suppression of detrusor hyperreflexia in multiple sclerosis J Neurol Neurosurg Psychiatry 65 1998 957